Search


Current filters:




Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 32 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2021The Introduction of cPRA and Its Impact on Access to Deceased Donor Kidney Transplantation for Highly Sensitized Patients in AustraliaSypek, M.P.; Kausman, J.Y.; Watson, N.; Wyburn, K.; Holt, S.G.; Hughes, P.; Clayton, P.A.
2021Advanced glycation end products as predictors of renal function in youth with type 1 diabetesForbes, J.M.; Le Bagge, S.; Righi, S.; Fotheringham, A.K.; Gallo, L.A.; McCarthy, D.A.; Leung, S.; Baskerville, T.; Nisbett, J.; Morton, A.; Teasdale, S.; D’Silva, N.; Barrett, H.; Jones, T.; Couper, J.; Donaghue, K.; Isbel, N.; Johnson, D.W.; Donnellan, L.; Deo, P.; et al.
2021Strain-Guided Management of Potentially Cardiotoxic Cancer TherapyThavendiranathan, P.; Negishi, T.; Somerset, E.; Negishi, K.; Penicka, M.; Lemieux, J.; Aakhus, S.; Miyazaki, S.; Shirazi, M.; Galderisi, M.; Marwick, T.H.
2021Dual antiangiogenesis agents bevacizumab plus trebananib, without chemotherapy, in first-line treatment of metastatic colorectal cancer: results of a phase II studyMooi, J.; Chionh, F.; Savas, P.; Da Gama Duarte, J.; Chong, G.; Brown, S.; Wong, R.; Price, T.J.; Wann, A.; Skrinos, E.; Mariadason, J.M.; Tebbutt, N.C.
2021Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemiaOchi, Y.; Yoshida, K.; Huang, Y.-J.; Kuo, M.-C.; Nannya, Y.; Sasaki, K.; Mitani, K.; Hosoya, N.; Hiramoto, N.; Ishikawa, T.; Branford, S.; Shanmuganathan, N.; Ohyashiki, K.; Takahashi, N.; Takaku, T.; Tsuchiya, S.; Kanemura, N.; Nakamura, N.; Ueda, Y.; Yoshihara, S.; et al.
2021T-Cell Expression and Release of Kidney Injury Molecule-1 in Response to Glucose Variations Initiates Kidney Injury in Early Diabetes.Forbes, J.M.; McCarthy, D.A.; Kassianos, A.J.; Baskerville, T.; Fotheringham, A.K.; Giuliani, K.T.K.; Grivei, A.; Murphy, A.J.; Flynn, M.C.; Sullivan, M.A.; Chandrashekar, P.; Whiddett, R.; Radford, K.J.; Flemming, N.; Beard, S.S.; D'Silva, N.; Nisbet, J.; Morton, A.; Teasdale, S.; Russell, A.; et al.
2021Limited utility of plasma elafin as a biomarker for skin graft-versus-host disease following allogeneic stem cell transplantationGeorge, L.; Mahabal, G.; Mohanan, E.; Balasubramanian, P.; Peter, D.; Pulimood, S.; Lakshmi, K.; Jeyaseelan, L.; Abraham, A.; Srivastava, A.; Mathews, V.; George, B.
2021Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort studyWin, A.K.; Dowty, J.G.; Reece, J.C.; Lee, G.; Templeton, A.S.; Plazzer, J.P.; Buchanan, D.D.; Akagi, K.; Aksoy, S.; Alonso, A.; Alvarez, K.; Amor, D.J.; Ankathil, R.; Aretz, S.; Arnold, J.L.; Aronson, M.; Austin, R.; Backman, A.S.; Bajwa-ten Broeke, S.W.; Barca-Tierno, V.; et al.
2021AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancerOar, A.; Lee, M.; Le, H.; Wilson, K.; Aiken, C.; Chantrill, L.; Simes, J.; Nguyen, N.; Barbour, A.; Samra, J.; Sjoquist, K.M.; Moore, A.; Espinoza, D.; Gebski, V.; Yip, S.; Chu, J.; Kneebone, A.; Goldstein, D.
2021Adiposity and cancer: a Mendelian randomization analysis in the UK biobankAhmed, M.; Mulugeta, A.; Lee, S.H.; Mäkinen, V.P.; Boyle, T.; Hyppönen, E.